Eden Fucci
About Eden Fucci
Eden Fucci serves as Senior Vice President, Technical Operations at Passage Bio, appearing consistently in the company’s leadership disclosures across 2023–2025 investor materials . His remit aligns with Passage Bio’s emphasis on in‑house CMC capabilities to support PBFT02 development and potential future commercialization, as highlighted in company materials . Age, education, and a detailed biography are not disclosed in PASG’s SEC filings; Fucci is not listed among Named Executive Officers (NEOs) in the 2024–2025 proxies, which limits executive‑level compensation and ownership detail for him . Company‑wide executive annual bonuses are tied to corporate and individual goals focused on R&D, regulatory, financial, and other corporate objectives; specific targets/weightings for Fucci are not disclosed .
External confirmation of role: Passage Bio press release notes Fucci (SVP Technical Operations) participating in Chardan’s Genetic Medicines & Cell Therapy Manufacturing Summit .
Fixed Compensation
| Year | Base Salary ($) | Target Bonus % | Actual Bonus ($) | Notes |
|---|---|---|---|---|
| 2024–2025 | Not disclosed | Not disclosed | Not disclosed | Fucci is not an NEO in PASG’s proxies; salary/bonus detail is not provided for non‑NEOs . |
Performance Compensation
| Metric Framework | Weighting | Target | Actual/Payout | Vesting | Notes |
|---|---|---|---|---|---|
| Company executive bonus design centers on corporate and individual objectives across R&D, regulatory, financial and other corporate goals | Not disclosed | Not disclosed | Not disclosed | Not applicable | Disclosure provided at the company level; no Fucci‑specific metrics disclosed . |
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Beneficial ownership listing | Fucci does not appear in the “Security Ownership of Certain Beneficial Owners and Management” table (directors/NEOs/5% holders) as of March 18, 2024 . |
| Hedging/derivatives policy | Company prohibits hedging transactions by employees, officers, and directors; this policy strengthens alignment with shareholders . |
| Clawback policy | Compensation Recovery Policy adopted Oct 12, 2023 to recoup incentive pay after a financial restatement per SEC Rule 10D‑1 . |
Employment Terms
| Topic | Disclosure |
|---|---|
| Employment agreement, severance, and change‑in‑control terms | No PASG filing during 2023–2025 provides an Item 5.02 disclosing an employment agreement or compensatory arrangement specific to Fucci; 5.02 items in the period pertain to other directors/executives . |
Performance & Track Record Context (Role‑Relevant)
| Theme | Company Disclosure |
|---|---|
| CMC/Technical Operations relevance | PASG highlights leading in‑house CMC and analytical capabilities to support PBFT02 development and readiness for future commercialization—core to Technical Operations leadership . |
| Program/milestone backdrop | Company materials show milestones around PBFT02 (e.g., Cohort readouts and pivotal‑design feedback timelines), framing execution demands on Technical Ops . |
Investment Implications
- Transparency: Because Fucci is not a Named Executive Officer in PASG’s proxies, investor visibility into his base pay, bonus targets, equity grants, and ownership is limited; this constrains direct pay‑for‑performance and insider‑selling analysis for him .
- Alignment safeguards (company‑wide): PASG’s anti‑hedging policy and SEC‑compliant clawback enhance alignment and reduce risk of misaligned incentives across executives, including senior leaders like Fucci .
- Execution/retention lens: The company’s emphasis on in‑house CMC capabilities and PBFT02 advancement underscores the strategic importance of Technical Operations; maintaining continuity in this role appears operationally significant as the program advances .
- Monitoring catalysts: Watch for future Item 5.02 8‑Ks or proxy disclosures naming Fucci (e.g., promotions or becoming an NEO) that would reveal compensation structure, vesting schedules, and potential severance/CIC terms; recent 5.02 items in 2023–2025 address other appointees rather than Fucci .
- External confirmation of role: Company press release and investor materials consistently identify Fucci as SVP Technical Operations, providing ongoing confirmation of role/tenure even without proxy‑level compensation detail .